Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Western Union Co (WU) Price & Performance

Amylx Pharmaceuticals IncTrade
Western Union CoTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Western Union Co — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.53B), while Western Union Co trades at $7.05 (market cap $2.19B). The key difference: Amylx Pharmaceuticals Inc is the larger of the two by market cap, and Western Union Co pays a 13.37% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXWU
Market Cap
$2.53B$2.19B
Sector
HealthTechnology
52-Week High
$24.19$10.28
52-Week Low
$7.82$6.36
Enterprise Value
$2.28B$2.10B
Dividend Yield
13.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Western Union Co

Western Union (WU) trades at $7.08, down 1.12% today, with a bearish technical signal and recent earnings misses in Q1 and Q2 2026. Valuation ratios appear attractive with a P/E of 5.71 and P/S of 0.56, but revenue has declined from $4.5B in 2022 to $4.05B in 2025. The company maintains a strong dividend yield, paying $0.24 quarterly, and recently launched Stablecard with Rain to expand digital services.

The outlook is cautious due to earnings volatility and competitive pressures in money transfers. Opportunities include cost management and digital growth, but risks from declining retail performance and high debt levels persist. Analyst consensus is mixed with a $7.14 price target, reflecting uncertainty over turnaround efforts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Western Union Co

Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.

Read more on WU